LADENBURG THALMANN FINANCIAL SERVICES INC. - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2019$7,000
+250.0%
2,4000.0%0.00%
Q3 2019$2,0000.0%2,4000.0%0.00%
Q2 2019$2,000
-33.3%
2,4000.0%0.00%
Q1 2019$3,0000.0%2,4000.0%0.00%
Q4 2018$3,000
-80.0%
2,4000.0%0.00%
Q3 2018$15,000
-42.3%
2,4000.0%0.00%
Q2 2018$26,0000.0%2,4000.0%0.00%
Q1 2018$26,000
+85.7%
2,400
+20.0%
0.00%
Q4 2017$14,0002,0000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2019
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders